Elsevier

Journal of Theoretical Biology

Volume 297, 21 March 2012, Pages 73-87
Journal of Theoretical Biology

Modelling hepatitis C transmission over a social network of injecting drug users

https://doi.org/10.1016/j.jtbi.2011.12.008Get rights and content

Abstract

Hepatitis C virus (HCV) is a blood-borne virus that disproportionately affects people who inject drugs (PWIDs). Based on extensive interview and blood test data from a longitudinal study in Melbourne, Australia, we describe an individual-based transmission model for HCV spread amongst PWID. We use this model to simulate the transmission of HCV on an empirical social network of PWID. A feature of our model is that sources of infection can be both network neighbours and non-neighbours via “importing”. Data-driven estimates of sharing frequency and rate of importing are provided. Compared to an appropriately calibrated fully connected network, the empirical network provides some protective effect on the time to primary infection. We also illustrate heterogeneities in incidence rate of infection, both across and within node degrees (i.e., number of network partners). We explore the reduced risk of infection from spontaneously clearing cutpoint nodes whose infection status oscillates, both in theory and in simulation. Further, we show our model-based estimate of per-event transmission probability largely agrees with previous estimates at the lower end of the range 1–3% commonly cited.

Highlights

► We model the spread of HCV on an empirical social network of injecting drug users. ► The empirical network provides some protective effect on time to primary infection. ► We explore the reduced risk from a gateway node with oscillating disease status. ► Our estimate of per-event transmission probability agrees with previous estimates.

Introduction

Hepatitis C is a blood-borne virus that is estimated to infect 200 million people worldwide. Approximately 80–90% of HCV infections in Australia occur in PWID (NCHECR, 2006). The proportion of people infected with HCV who develop persistent or chronic infection is in the range of 50–70% (NCHECR, 2006). A subset of those with chronic infection is at risk of developing cirrhosis, liver failure and hepatocellular carcinoma. Mathematical modelling of the spread of HCV has a large role to play in projecting the future course of the epidemic (e.g., NCHECR, 2006, Vickerman et al., 2009, Hutchinson et al., 2006), assessing the benefits of possible behavioural interventions (e.g., NCHECR, 2009, Vickerman et al., 2007), and exploring the benefits and deployment strategies of potential vaccines and treatments (e.g., Hahn et al., 2009). Kretzschmar and Wiessing (2008) provide an overview of contemporary challenges in modelling HCV.

Previous models of HCV transmission have typically made some assumption of “mixing” (e.g., Mather and Crofts, 1999, Pollack, 2001, Esposito and Rossi, 2004, Salomon et al., 2002, Vickerman et al., 2007, Vickerman et al., 2009, Hahn et al., 2009, also Murray et al., 2003, NCHECR, 2009, NCHECR, 2006 in the Australian context). That is, members of a population are assumed to have contact with all other members of the population (Anderson and May, 1991). Typically these models are deterministic, using differential equations to model quantities such as the total numbers of susceptibles and infectives in “compartments” (e.g., Pollack, 2001, Murray et al., 2003, Esposito and Rossi, 2004, Salomon et al., 2002, Vickerman et al., 2007, Vickerman et al., 2009), although some use stochastic simulation (e.g., Mather and Crofts, 1999, Hutchinson et al., 2006, Hahn et al., 2009, Moneim and Mosa, 2009). As our understanding of HCV has grown, these models have become increasingly sophisticated. Yet, while mixing has proven to be a useful simplifying assumption, particularly for modelling large populations, these models lack empirically grounded, disease relevant contact patterns (networks), and so fail to capture individual heterogeneity. (Hutchinson et al., 2006 is noteworthy for using a basic non-mixing approach that randomly assigns and removes sharing partners to create a simple random network which varies from year to year.) It is increasingly recognised that contact networks are relevant for understanding the transmission dynamics of various viruses like HCV. (See Welch et al., 2011 and references therein for an overview.)

While there is a large body of research on social networks (primarily sexual contact networks) relevant to HIV transmission (e.g., Morris, 2004 and references therein), networks-based research in HCV is in its infancy (Aitken et al., 2004, Brewer et al., 2006, Wylie et al., 2006, De et al., 2007, Aitken et al., 2008, Miller et al., 2009). In the context of HCV, the contact network of PWID formed by sharing needles/syringes is arguably most relevant. (The importance of sharing of other related equipment such as filters and spoons is less certain. See De et al., 2008 for a review.) Only recently have data on PWIDs been collected with both blood samples and a social network component (e.g., Aitken et al., 2008, Miller et al., 2009) that allow estimating incidence rates in conjunction with creating/estimating the network itself.

Individual-based (or agent-based) stochastic models of disease transmission have become increasingly popular (e.g., Hutchinson et al., 2006, Hahn et al., 2009 for HCV). They appear well-suited both to modelling individual heterogeneity and to modelling the spread of disease on networks. Unfortunately, these models for HCV lack an empirically grounded contact network.

This paper describes the first individual-based stochastic model of HCV transmission based on an empirical social network of PWID. Our model was created: (1) to explore the role of the network in HCV transmission, and (2) to investigate epidemiological differences between using the latest developments in social network modelling with other common network models and compartmental (i.e., non-network) models. Our main quantities of interest are the incidence rate of primary and secondary infection and the time to primary infection. Our model, parameter estimates and social network are based on data collected in Melbourne, Australia in the “Networks 2” study of the Burnet Institute (Aitken et al., 2008, Miller et al., 2009). The empirical social network is based on extensive interview data and its derivation is described below. Sources of infection in our model include both network neighbours and a source of “imported infections” which is independent of the social network. The rate of imported infections is estimated from empirical data.

In this paper we investigate HCV transmission on our empirical network and on a fully connected network which represents a mixing assumption. We demonstrate a protective effect, on the time to primary infection, of the social network in comparison with a mixing assumption. We illustrate heterogeneities in rate of infection, both across and within node degrees. We explore the attenuated risk of infection from gateway nodes whose infection status oscillates, both in theory and in simulation. Further, our model-based estimate of per-event transmission probability is shown to largely confirm the estimate of Hahn et al. (2009) at the lower end of the range 1–3% commonly cited. A number of upcoming additional investigations are described in Discussion.

The rest of this paper is organized as follows. Section 2 describes the data, the social network, and how various parameters were estimated. Section 3 describes the individual-based model in detail and describes how calibration was used to determine the probability of transmission from a single sharing event. Section 4 describes results from numerous simulations and a theoretical treatment of the reduced risk of gateway nodes whose infection status oscillates, followed by a discussion in Section 5.

Section snippets

Determination of social network and parameters

In 2005 a prospective study of PWID using a social network approach was started in the urban environment of Melbourne, Australia. Aitken et al. (2008) and Miller et al. (2009) describe the study and some results. In short, people were interviewed about their injecting practices in the previous 3 months. They were asked to nominate up to five people whom they “used with” (i.e., intravenous drug use at the same place and time) and “shared with” (i.e., used injecting equipment before or after

Model and methods

To understand the role that social networks play in the transmission of HCV infection, we created an individual-based transmission model, simulating transmission at a resolution of weeks. In each simulated week, the simulation must identify who gets infected (transmission mechanism) and how long the infection lasts (infection duration). For meaningful results, comparable to observed data, appropriate calibration and initialisation must be performed. Two potential sources of infection are

Simulation results

Here we report results from a collection of simulations. In each case parameter values were calibrated for a target rate of 18.9 per 100 person-years at risk. Unless otherwise stated, 1800 independent iterations were performed and summary statistics were collected for a specified period after burn-in (52 simulated weeks unless otherwise specified). The node attribute of sharing frequency was taken from the observed network (122 less-frequent, 136 frequent) and remained unchanged for all nodes.

Discussion

Our objectives in this paper were to develop a detailed HCV transmission model based on data collected in Melbourne, Australia, use an empirically grounded injecting network of PWID to explore the role of the network in the HCV epidemic, and compare results using the network with those obtained using a mixing assumption. Our main quantities of interest were the incidence rate of primary and secondary infection and the time to primary infection. Differences between the results for the social

Summary

We have created an individual-based model of HCV transmission on an empirical social network of PWID to study the role of the network in the epidemic. A feature of our model is that sources of infection can be both network neighbours and non-neighbours via “importing”. The social network and some simulation parameters are based on a unique dataset collected in Melbourne, Australia. In particular, we show that for pairs that share less than weekly, sharing frequency for the pair is about 0.19

Contributors

DAR contributed to the data preparation, statistical analysis of the data, development and programming of the simulation model, examined potentially relevant articles about HCV transmission and treatment, examined articles on previous HCV modeling efforts, and prepared the first draft of the manuscript. GD contributed to the data preparation and created the empirical network of PWID. RSD contributed to the data preparation, development of the model, and examined potentially relevant articles

Acknowledgements

The authors are grateful to the field workers who collected the data that made this study possible. The authors wish to thank Jodie McVernon and James McCaw for providing useful advice and providing helpful computing resources, Campbell Aitken for useful comments on hepatitis C and data collection for the Melbourne study, and Justin Denholm for background on the presentation and treatment of HCV. The authors also appreciate the support of the Australian Research Council (ARC) (Grant DP 0987730)

References (43)

  • A.L. Barabási et al.

    Emergence of scaling in random networks

    Science

    (1999)
  • D.D. Brewer et al.

    Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors

    J. Infect. Dis.

    (2006)
  • F. Cãruntu et al.

    Acute hepatitis C virus infection: diagnosis, pathogenesis, treatment

    J. Gastrointest. Liver Dis.

    (2006)
  • P. De et al.

    Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks

    J. Acquir. Immune. Defic. Syndr.

    (2007)
  • P. De et al.

    Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review

    J. Viral Hepat.

    (2008)
  • D.P. Gaver

    Random hazard in reliability problems

    Technometrics

    (1963)
  • J. Grandell

    Doubly stochastic Poisson processes

  • Iversen, J., Topp, L., Maher, L., 2007. Australian NSP Survey National Data Report 2002–2006. National Centre in HIV...
  • M. Kretzschmar et al.

    New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users

    AIDS

    (2008)
  • Krivitsky, P., Handcock, M., 2010. A separable model for dynamic networks....
  • J. Kwon et al.

    The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis

    J. Acquir. Immune. Defic. Syndr.

    (2009)
  • Cited by (45)

    • A review of network simulation models of hepatitis C virus and HIV among people who inject drugs

      2021, International Journal of Drug Policy
      Citation Excerpt :

      Alongside these benefits, there are a number of drawbacks to using dynamic models. As noted by Rolls et al. (2012), dynamic network models are complicated to develop due to the subtleties of tie formation and dissolution. In situations where little data exist to inform network models, investigators have argued that a static model requires fewer assumptions and is, therefore, a better choice (Cousien et al., 2017; Hellard et al., 2014).

    • Prioritising Hepatitis C treatment in people with multiple injecting partners maximises prevention: A real-world network study

      2020, Journal of Infection
      Citation Excerpt :

      When this occurred the susceptible individual developed acute infection, which progressed to chronic infection at 24 weeks with a fixed probability (Fig. 1). In line with other studies we did not adjust the susceptibility of infection in exposed uninfected individuals.12 The only way an individual could become infected with HCV in the simulation was via an injecting relationship.

    • Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies

      2019, Journal of Theoretical Biology
      Citation Excerpt :

      Several modeling studies have addressed the question of whether network-based treatment targeting approaches could maximize prevention benefits, using empirically derived individual-based network models. Hellard and colleagues published a series of stochastic individual-based network models of HCV transmission of PWID calibrated to detailed injecting network data among PWID in Melbourne, Australia (Hellard et al., 2014, 2015; Rolls et al., 2013, 2012). These studies used exponential random graph models (ERGMs) to simulate injecting relationships, and assume static networks.

    View all citing articles on Scopus
    View full text